Related Experiment Video
Updated: May 19, 2026

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
[Different Her-2 status in infiltrative and intraductal components of the breast cancer]
Arkhiv Patologii
|August 14, 2012
Abstract:
In the article a breast cancer case with different Her2 status in invasive and non-invasive components is described. We emphasize on the importance of knowledge about tumor histology for correct interpretation of FISH Her2-test results.

